￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical drugs

Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Lorlatinib (lorlatinib), an innovative targeted drug for ALK-positive non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Could lorlatinib (lorlatinib) be an alternative treatment option after resistance to ensartinib develops?

2026-02-01 22:25:32

Check Details
What is the primary therapeutic target of lorlatinib?

2026-02-01 22:25:32

Check Details
The current selling price of regorafenib in the Chinese market

2026-02-01 22:25:32

Check Details
Dietary precautions while taking regorafenib

2026-02-01 22:25:32

Check Details
How effective is regorafenib in the treatment of cancer metastasis?

2026-02-01 22:25:32

Check Details
How effective is regorafenib in anti-cancer treatment?

2026-02-01 22:25:32

Check Details
What is the latest price of Pfizer’s new drug talazoparib?

2026-02-01 22:25:32

Check Details
Talazoparib manufacturer and drug description

2026-02-01 22:25:32

Check Details
Is talazoparib effective?

2026-02-01 22:25:32

Check Details
The launch status of talazoparib in China in 2024 and the latest information on medical insurance

2026-02-01 22:25:32

Check Details
Detailed explanation of the price and purchase method of generic talazoparib

2026-02-01 22:25:32

Check Details
Category
相关知识